Thursday, August 08, 2013 6:23:53 PM
I believe FDA is realizing the breakthrough bio-nanotechnology drug delivery system before them, they see now what is involved here and how fast Nanoviricides, Inc. can turn around come up with a virus-destroyer drug.
Nanoviricides, Inc. has 9 anti-viral drugs in their current pipeline that have already undergone extensive testing in over 5000 animals. No evidence of toxicity. No side effects!
Dr. Seymour said, "...we are a company...with the ability to rapidly create drugs, and when I say rapidly create drugs I'm talking about weeks instead of years..." The FDA has probably come to realize that they need to streamline Priority Review from the normal six months to "a few short months". That means "Priority Review" could very well culminate 4Q 2013.
Nanoviricides, Inc. is not the only one making the case, before the FDA, for the breakthrough bio-nanotechnology drug delivery system that terminates viruses, threatens and kills people worldwide. It is all the prestigious universities, schools of medicine, and others that are Nanoviricides, Inc. collaborators. It is all those countries, countries that will add up to more that 100 worldwide before the end of 2013, that will be issuing patents to protect Nanoviricides, Inc. Intellectual Property. ---
Like "LEGO pieces" you plug-in the nano-micelle and bio-mimetic receptor protein (mimics target cell of the virus) together to produce the most lethal enemy to a human-killing virus.
"by the way, I'm sure that when you think human trials for drugs you think of hundreds of millions of dollars and years of time, well in this case because the disease only lasts a week, two weeks,...that it is possible to complete human trials in the space of a few short months...four parts to the human trials" ~ Dr. Eugene Seymour, Nanoviricides, Inc. CEO. Why would Dr. Seymour state this if the schedule of events is, to some extent, controlled by the FDA? This is the Nanoviricides, Inc. point of view that I believe has been presented to the FDA.
I am musing that the body of evidence before them is such that FDA has agreed to streamline the "Priority Review" and human trials. I'm speculating of course. Lets also keep in mind that "millions and millions not spent are millions and millions saved" in the human trials. How would that look for Nanoviricides, Inc. bottom line? Are we going to have more collaborators for the human trials 2014? You bet we are going to.
What about the other Nano-Cides? They are part of the same breakthrough drug delivery platform. Will they also get fast-tracked? I don't call it the Nano-Cides Special for nothing! ---
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM